Quantbot Technologies LP Acquires Shares of 145,689 Corteva, Inc. $CTVA

Quantbot Technologies LP bought a new position in Corteva, Inc. (NYSE:CTVA) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 145,689 shares of the company’s stock, valued at approximately $9,853,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CTVA. Vanguard Group Inc. boosted its position in shares of Corteva by 0.5% in the second quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock worth $5,976,436,000 after buying an additional 373,680 shares during the period. Geode Capital Management LLC increased its position in Corteva by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock worth $1,339,651,000 after purchasing an additional 251,693 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Corteva by 4.9% during the 2nd quarter. Franklin Resources Inc. now owns 17,680,238 shares of the company’s stock worth $1,317,708,000 after purchasing an additional 824,451 shares in the last quarter. Norges Bank acquired a new stake in shares of Corteva during the 2nd quarter valued at about $434,220,000. Finally, Bank of New York Mellon Corp grew its stake in shares of Corteva by 2.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,256,845 shares of the company’s stock valued at $391,793,000 after buying an additional 138,484 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE:CTVA opened at $80.01 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a 50-day moving average price of $71.91 and a 200 day moving average price of $68.83. The firm has a market capitalization of $53.81 billion, a PE ratio of 50.64, a price-to-earnings-growth ratio of 2.69 and a beta of 0.75. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.23.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Analyst Ratings Changes

A number of research firms have issued reports on CTVA. Royal Bank Of Canada lifted their target price on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Bank of America lifted their price objective on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. Mizuho raised their target price on Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a report on Tuesday, February 17th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $82.30.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.14% of the stock is owned by corporate insiders.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.